Conference Highlights
DCTs involve collaboration between study sponsors, research teams, the National TeleOncology Service, and participant sites. Read More ›
USU researchers noted they used observational retrospective analysis, with longitudinal data from the National Healthcare Safety Network that included about 48 hospitals and researcher surveys for both inpatient and outpatient clinics to take a more comprehensive, system-wide look at ASPs, since most available data has been at the facility level, rather than the entire system. Read More ›
Awards acknowledge the abilities of many outstanding federal healthcare individuals each year. Read More ›
Initial treatment with monoclonal antibodies alone did not boost the risk for other cancers (OCs) in a group of US veterans who had been diagnosed with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL), but initial treatment with chemoimmunotherapy was associated with a significant increase of OCs, according to results of a recently presented study. Read More ›
Addressing modifiable risk factors for anticoagulant-related bleeding in patients with cancer is an effective way to reduce bleeding and enable these patients to continue anticoagulant therapy, according to the results of a recently presented study at the 66th ASH Annual Meeting & Exposition held in San Diego, CA. Read More ›
Later cancer treatment initiation and fewer treatment options once treatment starts are just some of the impacts of longer driving distances to treatment, according to researchers reporting in a study presented at the 66th ASH Annual Meeting & Exposition held in San Diego, CA. Read More ›
Machine learning may hold promise for analyzing cells coexpressing MYC and BCL2 but lacking BCL6 (M+2+6-) in diffuse large B-cell lymphoma (DLBCL), which can be associated with poorer survival patterns, according to a study presented at the 66th ASH Annual Meeting & Exposition held in San Diego, CA. Read More ›
In patients with newly diagnosed multiple myeloma (NDMM), the use of anti-CD38 monoclonal antibodies (mAbs) enhances the effectiveness of standard treatment protocols, according to a study presented at the 66th ASH Annual Meeting & Exposition in San Diego, CA. Read More ›
A prevalence of 6-fold higher-than-average reported in the National Health and Nutrition Examination Survey Study of light-chain (LC) monoclonal gammopathy of undetermined significance (MGUS) has been shown in US service members (SMs), but does not appear to be linked to burn pit exposure, according to a study presented at the 66th ASH Annual Meeting & Exposition held in San Diego, CA. Read More ›
At least one base pharmacy will be investigating ways to engage military personnel who don’t use the pharmacy, after a survey underscored some key barriers to pharmacy access. Read More ›